Literature DB >> 1859878

Secondary erythrocytosis due to a cerebellar hemangioblastoma: demonstration of erythropoietin mRNA in the tumor.

M Trimble1, J Caro, A Talalla, M Brain.   

Abstract

Cerebellar hemangioblastoma is a rare cause of secondary erythrocytosis. Although the erythrocytosis is a result of erythropoietin (Ep) stimulation, direct evidence of Ep synthesis by the tumor has been lacking. In an erythrocytotic patient with a cerebellar hemangioblastoma we found elevated levels of Ep in the tumor cyst fluid and for the first time demonstrated Ep mRNA in the tumor by Northern blotting. This finding confirms cerebellar hemangioblastoma as a site of ectopic Ep production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1859878

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

2.  Cerebellar hemangioblastoma presenting as secondary erythrocytosis and aspiration pneumonia.

Authors:  H M Farrukh
Journal:  West J Med       Date:  1996-02

3.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

Authors:  Pinelopi P Kapitsinou; Qingdu Liu; Travis L Unger; Jennifer Rha; Olena Davidoff; Brian Keith; Jonathan A Epstein; Sheri L Moores; Connie L Erickson-Miller; Volker H Haase
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.

Authors:  Katarzyna Aleksandra Jalowiec; Kristina Vrotniakaite-Bajerciene; Jakub Jalowiec; Noel Frey; Annina Capraru; Tatiana Wojtovicova; Raphael Joncourt; Anne Angelillo-Scherrer; Andre Tichelli; Naomi Azur Porret; Alicia Rovó
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

Review 5.  Paraneoplastic manifestations in children.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

6.  Localization of specific erythropoietin binding sites in defined areas of the mouse brain.

Authors:  M Digicaylioglu; S Bichet; H H Marti; R H Wenger; L A Rivas; C Bauer; M Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

7.  Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature.

Authors:  Kosuke Ueda; Shigetaka Suekane; Katsuaki Chikui; Makoto Nakiri; Fukuko Moriya; Tokumasa Hayashi; Jiro Miyajima; Kei Matsuoka
Journal:  Mol Clin Oncol       Date:  2012-08-03

8.  Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines.

Authors:  Yutaka Fujisue; Takatoshi Nakagawa; Kiyoshi Takahara; Teruo Inamoto; Satoshi Kiyama; Haruhito Azuma; Michio Asahi
Journal:  Oncol Lett       Date:  2013-04-03       Impact factor: 2.967

9.  Polyglobulia in patients with hemangioblastomas is related to tumor size but not to serum erythropoietin.

Authors:  Marie T Krüger; Jan-Helge Klingler; Cordula Jilg; Christine Steiert; Stefan Zschiedrich; Vera Van Velthoven; Sven Gläsker
Journal:  Hered Cancer Clin Pract       Date:  2018-09-11       Impact factor: 2.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.